Posts by: Patricia Inacio PhD

Patricia Inacio PhD

Patricia holds a Ph.D. in Cell Biology from University Nova de Lisboa, and has served as an author on several research projects and fellowships, as well as major grant applications for European Agencies. She has also served as a PhD student research assistant at the Department of Microbiology & Immunology, Columbia University, New York.

July 15, 2016July 15, 2016

Key Protein May Lead to Novel IBD Therapies for Colon Inflammation, Crohn’s, Ulcerative Colitis

Colon Cancer, Crohn's Disease, IBD News, News, Ulcerative colitis

Researchers identified a novel cellular mechanism responsible for increasing inflammation in the colon (large intestine), a common feature triggering Crohn’s disease, ulcerative colitis, even colon cancer. The study, “Itch inhibits ... Read more

July 5, 2016July 5, 2016

Regular Yoga Practice Seen to Ease Disease Activity in Ulcerative Colitis Patients

News, Ulcerative colitis

Ulcerative colitis patients who practiced hatha yoga for 12 weeks experienced reductions in disease activity and saw significant improvements in their quality of life and mental health, according to a ... Read more

June 16, 2016June 16, 2016

Severe Pediatric Onset IBD May See New Therapy Via Three-Part Venture

IBD News, News

Medgenics recently announced a partnership with Kyowa Hakko Kirin to develop and commercialize the company’s first-in-class anti-LIGHT monoclonal antibody for severe pediatric onset inflammatory bowel disease (IBD). Plans are in the works to begin signal ... Read more

June 7, 2016June 7, 2016

Some Crohn’s Disease Patients Reach Remission with Risankizumab

Crohn's Disease, IBD News, News

Phase 2 clinical trial results showed that patients with moderate to severe active Crohn’s disease can achieve disease remission when treated with risankizumab, a Boehringer Ingelheim investigational biologic product. The study, “IL-23 ... Read more

May 2, 2016May 2, 2016

Certain Drug Therapies for Pregnant Women with IBD Can Have Impact on Newborns

News

Infants born to women who were treated with antibodies against tumor necrosis factor alpha (TNF alpha) during pregnancy have detectable levels of antibodies until 12 months of age, according to the results ... Read more

April 29, 2016June 23, 2016

Inflammatory Agent in IBD, TNF-alpha, Found to Also Promote Healing in Colon

IBD News, News

Researchers discovered that the molecule TNF-alpha has a dual role in inflammatory bowel disease (IBD). While long known to promote the disease, TNF-alpha has also been found to promote key immune ... Read more

January 14, 2016January 14, 2016

Gene Expression in Diseases Like Crohn’s Controlled by DNA Repeaters

News

In a new study, researchers performed a global genome-wide analysis and showed that DNA regions with short repeat units, called Short Tandem Repeats (STRs), are key players regulating gene expression ... Read more

December 12, 2015December 14, 2015

IBD Risk May Rise with Red Meat Consumption

News

Researchers in a meta-analysis study found a correlation between increased risk for inflammatory bowel disease (IBD) and meat consumption, particularly among individuals who consumed red meat. The study, titled “Meat ... Read more

December 3, 2015December 3, 2015

IBD Onset and Exacerbations Follows No Seasonal Pattern in Children

News

In a new study entitled “Seasonal variations in onset and exacerbation of inflammatory bowel diseases in children,” a team of researchers investigated if inflammatory bowel disease (IBD) exacerbations and IBD’s ... Read more

November 20, 2015November 20, 2015

Successful Remission in Ulcerative Colitis Patients Achieved Using Combination Therapy

News

In a new study entitled “Combination Therapy With Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis,” a team of researchers investigated if a combined ... Read more